目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Food Allergy Diagnostics and Therapeutics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Food Allergy Diagnostics and Therapeutics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Food Allergy Diagnostics and Therapeutics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Food Allergy Diagnostics and Theraoeutics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Diagnostics
4.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Therapeutics
4.4.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Antihistamines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Epinephrine Auto-injector Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Food Allergy Diagnostics and Therapeutics Market: Allergen Source Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Food Allergy Diagnostics and Therapeutics Market: Allergen Source Analysis, 2023 & 2030 (USD Million)
5.3. Peanuts
5.3.1. Peanuts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Milk
5.4.1. Milk Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Eggs
5.5.1. Eggs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Fish
5.6.1. Fish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Shellfish
5.7.1. Shellfish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Tree Nuts
5.8.1. Tree Nuts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Wheat
5.9.1. Wheat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Soy
5.10.1. Soy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Others
5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Food Allergy Diagnostics and Therapeutics Market: End use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Food Allergy Diagnostics and Therapeutics Market: End use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals and Clinics
6.3.1. Hospitals And Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Academic Research Institutes
6.4.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Diagnostics Laboratories
6.5.1. Diagnostics Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Food Allergy Diagnostics and Therapeutics Market: Regional Estimates & Trend Analysis
7.1. Food Allergy Diagnostics and Therapeutics Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.4. France
7.3.4.1. France Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Spain Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
7.3.6. Denmark
7.3.6.1. Denmark Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
7.3.7. Sweden
7.3.7.1. Sweden Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
7.3.8. Norway
7.3.8.1. Norway Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1 Allergy Therapeutics
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Cambridge Allergy Limited
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Astellas Pharma, Inc
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Immunomic Therapeutics, Inc
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Prota Therapeutics Pty Ltd
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Aimmune Therapeutics
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Meridian Medical Technologies
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. ALK-Abello Ltd
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Medeca Pharma AB
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. bioMerieux SA
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. Omega Diagnostics Group PLC
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
8.4.12. HYCOR Biomedical
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/ Strategic Initiatives
8.4.13. HOB Biotech Group PLC
8.4.13.1. Participant’s Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Recent Developments/ Strategic Initiatives